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Abstract
Introduction: Plasmid-mediated quinolone resistance (PMQR) is a growing clinical concern worldwide. The main aims of this 
study were to detect qnr-encoding genes and to evaluate the clonal relatedness of qnr-positive Enterobacter cloacae isolates. 
Methods: A total of 116 E. cloacae isolates that were not susceptible to quinolone were obtained from seven hospitals in Tehran, 
five hospitals in Qazvin, and two hospitals in Karaj (Iran). Bacterial identification was performed using standard laboratory methods 
and API 20E strips. Quinolone resistance was determined using the Kirby-Bauer disk diffusion method according to the Clinical 
Laboratory Standards Institute (CLSI) guidelines. PCR and sequencing were employed to detect qnrA, qnrB, and qnrS genes, and 
clonal relatedness was assessed using the enterobacterial repetitive intergenic consensus (ERIC)-PCR method. Results: In total, 
45 (38.8%) and 71 (61.2%) of isolates showed high- and low-level quinolone resistance, respectively, and qnr-encoding genes were 
detected in 70 (60.3%) of them. qnrB1 [45 (38.8%) isolates] was the most commonly detected gene, followed by qnrS1 [28 (24.1%) 
isolates] and qnrB4 [18 (15.5%) isolates] either alone or in combination with other genes. The results of the ERIC-PCR revealed 
that 53 (75.7%) qnr-positive isolates were genetically unrelated. Conclusions: This study describes, for the first time, the high 
prevalence of the qnrB1, qnrS1, and qnrB4 genes among E. cloacae isolates in Iran. The detection of qnr genes emphasizes the need 
for establishing tactful policies associated with infection control measures in hospital settings in Iran.
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Enterobacter cloacae is a clinically significant gram-negative 
bacterium that can cause several clinical diseases such as urinary 
tract infections, bacteremia and sepsis, lower respiratory tract 
infections, pneumonia, and soft tissue infections(1). Health care 
for patients with infections caused by this organism has been 
associated with high mortality and morbidity, especially among 
patients admitted in intensive care units (ICUs)(2) (3). 
Nowadays, quinolones are being frequently used to treat serious 
infections caused by enterobacteria in hospital settings(4) (5). Extensive 
and inappropriate use of quinolones and other such antimicrobial 
agents has increased multidrug resistance in Enterobacter 
cloacae (MDREC) isolates, which complicates and limits the 
process of antimicrobial therapy(6) (7).
Resistance to quinolone compounds is often due to 
chromosomal point mutations in deoxyribonucleic acid (DNA) 
gyrase and/or topoisomerase IV(8). However, plasmid-mediated 
quinolone resistance (PMQR) has also been reported in several 
parts of the world(9) (10) (11) (12) (13) (14). Plasmids carrying qnr genes 
widely vary in size and typically carry multiple resistance 
determinants(15) (16). Qnr proteins are members of a pentapeptide 
repeat protein family, which is capable of protecting DNA gyrase 
and DNA topoisomerase IV from quinolone compounds(17). For 
example, QnrB4 is a characterized pentapeptide repeat protein 
that interacts with DNA gyrase(18). Antibiotic treatment against 
infections caused by qnr-positive isolates is more complicated 
because of the remarkable ability of these organisms to develop 
resistance to different antibiotic classes as well as their high 
potential for transmitting antibiotic resistance between different 
bacterial species(19) (20). Three major groups of qnr determinants, 
qnrA, qnrB, and qnrS, are increasingly being identified in clinical 
isolates of various enterobacterial species worldwide(21). The first 
PMQR gene was reported in a Klebsiella pneumoniae isolate from 
Birmingham in 1994(22). Later, these genes were also reported in 
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TABLE 1 - Primers used for the detection of qnr genes in Enterobacter cloacae isolates.
Target genes Primer sequence (5'-3') Annealing temperature (°C)
qnrA1–6 Forward: ACGCCAGGATTTGAGTGAC 53
 Reverse: CCAGGCACAGATCTTGAC 
qnrB1-3, 5, 6, 8 Forward: GGCACTGAATTTATCGGC 49
 Reverse: TCCGAATTGGTCAGATCG 
qnrB4 Forward: AGTTGTGATCTCTCCATGGC 53
 Reverse: CGGATATCTAAATCGCCCAG 
qnrS1–2 Forward: CCTACAATCATACATATCGGC 53
 Reverse: GCTTCGAGAATCAGTTCTTGC 
qnr: quinolone resistance.
other clinical isolates such as Enterobacter spp.(21), Escherichia 
coli,(23) Salmonella spp.(24), and Citrobacter freundii(25).
To the best of our knowledge, there has been no report so 
far on the frequency of qnr genes among E. cloacae isolates in 
Iran. In this study, for the first time, we described the frequency 
of qnr determinants (qnrA, qnrB, and qnrS) among E. cloacae 
isolates that are non-susceptible to quinolone isolates collected 
from hospitals of the Qazvin, Alborz, and Tehran provinces in 
Iran. This study emphasizes the need for establishing specific 
policies for infection control measures in hospital settings in Iran.
METHODS
Bacterial isolates and antimicrobial susceptibility
In this cross-sectional descriptive study, 116 quinolone 
non-susceptible E. cloacae isolates (one isolate per patient) 
were obtained from the clinical samples of patients admitted 
to the university hospitals of Tehran (seven hospitals), Qazvin 
(five hospitals), and Karaj (two hospitals) in Iran. The samples 
were collected from June 2013 to October 2014. The bacteria 
were isolated from various clinical specimens including tracheal 
aspirates, urine, sputum, blood, bronchoalveolar lavage (BAL), 
wounds, and cerebrospinal fluid. Bacterial identification was 
initially performed using standard laboratory methods, and the 
results were then confirmed using the API 20 E (bioMérieux, 
France) microorganism identification system. The isolates were 
stored at -70°C in trypticase soy broth containing 20% glycerol 
and subcultured twice prior to testing. Written informed consent 
was obtained from all the patients enrolled in this study. Kirby-
Bauer disk diffusion testing was performed according to the 
Clinical Laboratory Standards Institute (CLSI) guideline to 
detect quinolone resistance using nalidixic acid (10µg) and 
ciprofloxacin (5µg)(26). The antibiotic disks were purchased 
from the Mast (Mast Diagnostics Group Ltd, Merseyside, UK). 
If resistance to both the antibiotics was detected, the isolates 
were classified as showing high-level quinolone resistance. On 
the other hand, nalidixic acid-resistant or -intermediate isolates 
and ciprofloxacin-susceptible isolates were classified as showing 
low-level quinolone resistance(13). Escherichia coli American 
Type Culture Collection (ATCC) 25922 and Pseudomonas 
aeruginosa ATCC 27853 were used as the quality control strains 
for antimicrobial susceptibility testing.
PCR and sequencing of qnr-encoding genes
All the isolates were subjected to PCR for the detection of 
the qnrA, qnrB, and qnrS PMQR genes using specific primers 
(Table 1)(27). Plasmid DNA was extracted using the plasmid mini 
extraction kit (Bioneer Company, Korea).
PCR amplifications were performed in a thermocycler 
(Applied Biosystems, USA) as follows: 95°C for 5 min and 35 
cycles of 1 min at 95°C, 1 min at specific annealing temperature 
for each primer and 1 min at 72°C. A final extension step of 
10 min at 72°C was performed. The reaction mixtures were 
prepared in a total volume of 25μl (24μl of PCR master mix 
plus 1μl of template DNA) including 5ng of genomic DNA, 
2.0U of Taq DNA polymerase, 10mM dNTP mix at a final 
concentration of 0.2mM, 50mM MgCl
2
 at a final concentration 
of 1.5mM, 1μM of each primer, and 10X PCR buffer in final 
concentration of 1X. 
The PCR products were electrophoresed on 1% agarose gel at 
100 volts and were then stained with ethidium bromide solution 
and visualized in a gel documentation system (UVtec, UK). 
The purified PCR products were sequenced by the Macrogen 
Company (Seoul, Korea), and sequence alignment and analysis 
were performed online using the Basic Local Alignment Search 
Tool (BLAST) program of the National Center for Biotechnology 
Information (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Molecular typing by enterobacterial repetitive intergenic 
consensus-PCR
All the qnr-positive E. cloacae isolates were tested for 
epidemiological relationships using enterobacterial repetitive 
intergenic consensus (ERIC)-PCR as previously described by 
Smith et al.(28) The PCR cycling conditions were as follows: 
denaturation at 94°C for 1 s, annealing at 52°C for 10 s, and 
extension at 72°C for 35 s for 30 cycles, followed by a final 
extension at 72°C for 4 min. The resulting products were 
analyzed on 1.5% agarose gels. Fingerprints were compared 
visually, and patterns differing by two or more bands were 
classified as different.
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TABLE 2 - Distribution of the qnrB1, qnrB4, and qnrS1 genes among 70 qnr-positive Enterobacter cloacae isolates.
                    Isolates 
 low level resistance high level resistance Total
qnr-encoding genes n % n % n %
qnrB1 10 14.3 21 30.0 31 44.3
qnrS1 8 11.4 7 10.0 15 21.4
qnrB4 5 7.1 1 1.4 6 8.6
qnrB1+ qnrS1 2 2.9 4 5.7 6 8.6
qnrB1+ qnrB4 4 5.7 1 1.4 5 7.1
qnrS1+ qnrB4 3 4.3 1 1.4 4 5.7
qnrB1+ qnrB4+ qnrS1 - - 3 4.3 3 4.3
Total 32 45.7 38 54.3 70 100.0
qnr: quinolone resistance.
Statistical analysis
Statistical analysis was performed for descriptive statistics 
including frequencies and cross tabulation of microbiological, 
clinical, and demographic characteristics using the computer 
software program Statistical Package for the Social Sciences 
(SPSS) version 16.
RESULTS
During the study period, 116 quinolone non-susceptible 
E. cloacae isolates were recovered from different clinical 
specimens; 42 (36.2%) were isolated from urine specimens, 
28 (24.1%) from wound specimens, 18 (15.5%) from tracheal 
specimens, 17 (14.7%) from blood specimens, 5 (4.3%) from 
sputum specimens, 4 (3.4%) from bronchoalveolar lavage 
specimens, and 2 (1.7%) from cerebrospinal fluid specimens. 
The isolates were obtained from 47 (40.5%) patients admitted to 
ICUs, 31 (26.7%) from those admitted to the internal medicine 
ward, 14 (12.1%) from the infectious diseases ward, 9 (7.8%) 
from the surgery ward, 9 (7.8%) from the orthopedic ward, and 
6 (5.2%) from the neurology ward. The mean age of the patients 
was 51.7 ± 17.4 years (range: 17-83 years); 69 (59.5%) patients 
were male and 47 (40.5%) were female.
The results of the disk diffusion test showed that 93 (80.2%) 
isolates were fully resistant to nalidixic acid and 23 (19.8%) 
showed intermediate resistance. Forty-three (37.1%) isolates were 
fully resistant to ciprofloxacin and 2 (1.7%) showed intermediate 
resistance to it. In total, 45 (38.8%) and 71 (61.2%) isolates 
showed high- and low-level quinolone resistance, respectively.
PCR and sequencing revealed that the qnr-encoding genes 
were present in 70 (60.3%) of the quinolone non-susceptible 
E. cloacae isolates; among them, qnrB1 [45 (38.8%) isolates] 
was the most commonly detected gene, followed by qnrS1 
[28 (24.1%) isolates] and qnrB4 [18 (15.5%) isolates] either 
alone or in combination with other genes. The qnrB1 gene 
was found to coexist with qnrS1 in 6 (8.6%) isolates; 5 (7.1%) 
isolates also carried both qnrB1 and qnrB4, and 3 (4.3%) 
isolates carried the qnrS1, qnrB1, and qnrB4 genes. In this 
study, the presence of the qnrA gene was not detected. In total, 
38 (54.3%) isolates showing high-level quinolone resistance and 
32 (45.7%) showing low-level quinolone resistance carried the 
qnr genes. The most common gene found among the isolates 
showing high- and low-level quinolone resistance was qnrB1 
(Table 2). qnr-positive isolates were mostly recovered from 
wound specimens (19%), followed by urine samples (15.5%). 
The patients infected by these organisms were mostly admitted 
to the ICU (26.7%) and the internal medicine (12.1%) wards 
(Table 3). The ERIC-PCR results revealed that 53 (75.7%) 
qnr-encoding isolates showed different genotypes and had 
distinct ERIC-PCR patterns, indicating clear heterogeneity in 
their genetic profiles (Table 4).
DISCUSSION
Enterobacter cloacae has been increasingly recognized as 
a clinically significant nosocomial pathogen(29). Quinolones 
are among the most commonly prescribed antimicrobials for 
the treatment of serious infections caused by E. cloacae and 
other members of the Enterobacteriaceae family. However, the 
development of resistance to these antibiotics in the causative 
bacteria has complicated treatment and may lead to treatment 
failures(30). In recent years, PMQR has been reported in several 
studies, especially in enterobacteria(8). However, there is limited 
data on the prevalence of qnr genes among enterobacteria 
isolates in Iran(14) (31). To the best of our knowledge, this is the first 
report on the detection of qnrB1, qnrB4, and qnrS1 determinants 
among quinolone non-susceptible E. cloacae isolates in Iran.
The present study demonstrated a high (60.3%) prevalence 
of PMQR determinants among quinolone non-susceptible 
E. cloacae isolates collected from several educational hospitals 
in Iran. The prevalence rate of these genes found in our study is higher 
than that reported by Dahmen et al(32). from Tunisia (16%)(32), Wu et al (10). 
from Taiwan (16.3%)(10), Kim et al(33). from Korea (17%)(33), and 
Robicsek et al(34). from the United States (31%)(34). However, the 
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TABLE 4 - Enterobacterial repetitive intergenic consensus-PCR result of the 70 qnr-positive Enterobacter cloacae isolates.
        Isolates
                                             Type A                          Type B                        Type C                  Independent types
qnr-encoding genes n % n % n % n %
qnrB1 4 5.7 2 2.9 - - 25 35.7
qnrB4 1 1.4 - - - - 5 7.1
qnrS1 2 2.9 2 2.9 2 2.9 9 12.9
qnrB1+qnrB4 - - - - - - 5 7.1
qnrB1+qnrS1 1 1.4 1 1.4 1 1.4 3 4.3
qnrB4+qnrS1 1 1.4 - - - - 3 4.3
qnrB1+qnrB4+qnrS1 - - - - - - 3 4.3
Total 9 12.8 5 7.2 3 4.3 53 75.7
PCR: polymerase chain reaction; qnr: quinolone resistance.
Peymani A et al. - qnr determinants in Enterobacter cloacae
TABLE 3 - Frequency of detection of the 70 qnr-positive Enterobacter cloacae isolates based on hospital wards and source of clinical 
specimens.
        Isolates        Isolates
Wards n % Specimens n %
ICU 31 26.7 Wound 22 19.0
Internal medicine 14 12.1 Urine 18 15.5
Orthopedic 7 6.0 Trachea 14 12.1
Neurology 7 6.0 Blood 11 9.5
Infectious diseases 6 5.2 Sputum 4 3.4
Surgery 5 4.3 BAL 1 0.9
ICU: intensive care unit; BAL: bronchoalveolar lavage.
prevalence rate reported in our study is lower than that reported 
by Bouchakour et al. in their study in Morocco, in which 62.5% 
of the E. cloacae isolates were found to carry qnr determinants(35). 
This may indicate that the rate of PMQR is increasing among 
enterobacteria. In a previous study, we reported that 53 (44.2%) 
of the E. cloacae isolates studied were extended-spectrum 
β-lactamase (ESBL) producers(36). Taken together, these data 
suggest that inappropriate and extensive use of broad-spectrum 
antibiotics has resulted in the emergence of resistant isolates in 
our hospital settings. Moreover, the high resistance rate found 
among the isolates in this study emphasizes the need for a local 
and national antimicrobial resistance surveillance system for 
monitoring the administration of antimicrobials and emergence 
of antibiotic resistance in bacterial isolates present in our hospital 
settings. The data on antibiotic resistance received from the 
hospital infection and antibiotic control committees can help 
encourage physicians to discontinue excessive use of antibiotics, 
which will eventually lead to better preventive measures for 
controlling hospital infections.
Moreover, we found that 54.3% of the qnr-positive isolates 
in this study showed high-level quinolone resistance. Since 
PMQR determinants confer only low-level resistance to 
quinolones, we hypothesize that the high-level resistance pattern 
is due to another mechanism such as chromosomal mutation; 
however, we could not test this hypothesis in the present study. 
Further, most of the qnr-positive E. cloacae isolates were 
frequently collected from patients admitted to ICUs, which is 
consistent with the reports of some previous studies(37) (38). This result 
suggests that prolonged stay in ICUs, exposure to broad-
spectrum antibiotics, chronic underlying conditions, and the use 
of invasive techniques and devices might predispose patients 
to infections caused by the aforementioned quinolone-resistant 
isolates.
In the present study, 38.8%, 24.1%, and 15.5% of the 
quinolone non-susceptible E. cloacae isolates carried the 
qnrB1, qnrS1, and qnrB4 genes, respectively, alone or in 
combination with other genes. In a previous study conducted 
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qnrB1 (1.2%), and qnrS (1.2%) genes among ESBL-producing 
Salmonella isolates(31). In Taiwan, Wu et al.(10) reported that 
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contained the qnrB2, qnrS1, and qnrA1 genes, respectively(10). 
In the United States, Robicsek et al.(34) showed that 20% and 
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qnrB genes, respectively(34). In Algeria, Iabadene et al.(15) reported 
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isolates(32). Thus, to the best of our knowledge, this is the first report 
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In addition, the ERIC-PCR analysis conducted in this study 
showed that more than 75% of the qnr-positive isolates were 
epidemiologically unrelated, suggesting that the dissemination of 
qnr-positive isolates was not due to a clonal outbreak. This is in 
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In conclusion, the results of this study revealed a high 
prevalence of PMQR due to the presence of qnr genes among 
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of these resistance determinants in clinical settings raises serious 
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therapy. The fact that PMQR determinants confer only low-
level resistance to quinolones and our finding that 54.3% of the 
qnr-positive isolates in our study showed high-level quinolone 
resistance suggest that another mechanism such as chromosomal 
mutation may be responsible for the high-level resistance 
observed. This hypothesis needs to be tested in future studies. 
Limitation of our study was laboratory resources. Nevertheless, 
our findings highlight the need for adopting appropriate infection 
control policies formulated by infection control committees 
and rational antibiotic administration by physicians to reduce 
the further spread of these resistant bacteria in our hospitals.
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